John T. Miura, MD
Assistant Professor of Surgery at the Hospital of the University of Pennsylvania
Active Surgeon, Department of Surgery, Pennsylvania Hospital, Philadelphia, PA
Active Surgeon, Department of Surgery, Penn Presbyterian Medical Center, Philadelphia, PA
Attending Surgeon, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA
Department: Surgery
Contact information
Hospital of the University of Pennsylvania
3400 Spruce Street
4 Silverstein Pavilion
Philadelphia, PA 19104
3400 Spruce Street
4 Silverstein Pavilion
Philadelphia, PA 19104
Office: 215 615-0758
Education:
B.S. (Biochemistry)
Beloit College, Beloit, WI, 2004.
M.D.
Medical College of Wisconsin, Milwaukee, WI, 2010.
Permanent linkB.S. (Biochemistry)
Beloit College, Beloit, WI, 2004.
M.D.
Medical College of Wisconsin, Milwaukee, WI, 2010.
Selected Publications
Vargas GM, Farooq MS, Shafique N, Lee MK, Vollmer CM, Miura JT, Karakousis GC.: Impact of Patient Income and Insurance on Postoperative Mortality After Total Pancreatectomy for Pancreatic Neoplasms. J Surg Oncol Aug 2025.Brown LM, Wilkins SG, Bansal VV, Su DG, Gomez-Mayorga J, Turaga KK, Gunderson CG, Lee B, Nash GM, Hays JL, Raghav KP, Husain AL, Kluger MD, Zauderer MG, Kindler HL, Alexander HR; Peritoneal Surface Malignancies Consortium Group.: Consensus guideline for the management of peritoneal mesothelioma. Cancer 131: e35868, Jul 2025.
Godfrey EL, Mahoney F, Bansal VV, Su DG, Hanna DN, Lopez-Ramirez F, Baron E, Turaga KK, Benson AB, Cusack J, Winer JH, Gunderson CG, Misdraji J, Shah R, Magge DR, Solsky I, Eng C, Eng OS, Shergill A, Shen JP, Foote MB; Peritoneal Surface Malignancies Consortium Group.: Consensus guideline for the management of patients with appendiceal tumors, part 1: Appendiceal tumors without peritoneal involvement. Cancer 131: e35867, Jul 2025.
Godfrey EL, Mahoney F, Bansal VV, Su DG, Hanna DN, Lopez-Ramirez F, Baron E, Turaga KK, Benson AB 3rd, Setia N, Winer JH, Gunderson CG, Shah R, Magge DR, Solsky I, Eng C, Eng OS, Shergill A, Shen JP, Misdraji J, Foote MB, Luo W; Peritoneal Surface Malignancies Consortium Group.: Consensus guideline for the management of patients with appendiceal tumors, part 2: Appendiceal tumors with peritoneal involvement. Cancer 131: e35874, Jul 2025.
Godfrey EL, Mahoney F, Bansal VV, Su DG, Hanna DN, Lopez-Ramirez F, Baron E, Turaga KK, Benson AB 3rd, Setia N, Winer JH, Gunderson CG, Shah R, Magge DR, Solsky I, Eng C, Eng OS, Shergill A, Shen JP, Misdraji J, Foote MB, Luo W; Peritoneal Surface Malignancies (PSM) Consortium Group.: Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 2: Appendiceal Tumors with Peritoneal Involvement. Ann Surg Oncol Jun 2025.
Godfrey EL, Mahoney F, Bansal VV, Su DG, Hanna DN, Lopez-Ramirez F, Baron E, Turaga KK, Benson AB 3rd, Cusack J, Winer JH, Gunderson CG, Misdraji J, Shah R, Magge DR, Solsky I, Eng C, Eng OS, Shergill A, Shen JP, Foote MB; Peritoneal Surface Malignancies (PSM) Consortium Group.: Consensus Guideline for the Management of Patients with Appendiceal Tumors, Part 1: Appendiceal Tumors Without Peritoneal Involvement. Ann Surg Oncol Jun 2025.
Brown LM, Wilkins SG, Bansal VV, Su DG, Gomez-Mayorga J, Turaga KK, Gunderson CG, Lee B, Nash GM, Hays JL, Raghav KP, Husain AL, Kluger MD, Zauderer MG, Kindler HL, Alexander HR; Peritoneal Surface Malignancies (PSM) Consortium Group.: Consensus Guideline for the Management of Peritoneal Mesothelioma. Ann Surg Oncol Jun 2025.
Farooq MS, Mattfeld V, Vargas GM, Shafique N, Miura JT, Karakousis GC. : Recurrence patterns and survival outcomes in clinical stage IIB/IIC melanoma: Can we stratify patients for consideration of neoadjuvant immunotherapy? Poster Presentation at the Ali Naji Research Day – University of Pennsylvania. May 7, 2025, Philadelphia, Pennsylvania. May 2025.
Vargas GM, Farooq MS, Shafique N, Ming ME, Miura JT, Karakousis GC.: Association between UV irradiation exposure by geographic region and stage at presentation in patients with melanoma. Society of Investigative Dermatology Conference. May 9, 2025. Poster presentation. May 2025.
Farooq MS, Ertmann E, Vargas GM, Shafique N, Mitchell TC, Schuchter LM, Amaravadi RK, Karakousis GC, Miura JT.: Combination ipilimumab/nivolumab for refractory Merkel cell carcinoma: a single-institution experience. Journal of Clinical Oncology May 2025.